Assignee
HAESSLE AB
SE71 patents
Top patents by PatentIndex Score
US4738974AApr 19, 1988
Base addition salts of omeprazole
HAESSLE AB183 citations98
US4508905AApr 2, 1985
Substituted 2-(-benzimidazolyl)pyridines
HAESSLE AB158 citations96
US4255431AMar 10, 1981
Gastric acid secretion inhibiting substituted 2-(2-benzimidazolyl)-pyridines, pharmaceutical preparations containing same, and method for inhibiting gastric acid secretion
HAESSLE AB374 citations96
US4853230AAug 1, 1989
Pharmaceutical formulations of acid labile substances for oral use
HAESSLE AB330 citations95
US4786505ANov 22, 1988
Pharmaceutical preparation for oral use
HAESSLE AB603 citations95
US4965269AOct 23, 1990
Therapeutically active chloro substituted benzimidazoles
HAESSLE AB84 citations94
US4636499AJan 13, 1987
Sulphenamides
HAESSLE AB74 citations94
US4620008AOct 28, 1986
Processes for the preparation of omeprazole and intermediates therefore
HAESSLE AB56 citations94
US4341759AJul 27, 1982
Granule having controlled release properties
HAESSLE AB85 citations94
US4337257AJun 29, 1982
Gastric acid secretion inhibiting substituted 2-(2-benzimidazolyl)-pyridines, their preparation, pharmaceutical preparations containing same, and method for inhibiting gastric acid secretion
HAESSLE AB122 citations94
US5201705AApr 13, 1993
Device for release of a substance
HAESSLE AB103 citations93
US5093342AMar 3, 1992
Use of omeprazole as an antimicrobial agent
HAESSLE AB85 citations93
US4927640AMay 22, 1990
Controlled release beads having glass or silicon dioxide core
HAESSLE AB244 citations93
US5246714ASep 21, 1993
Drug preparation
HAESSLE AB58 citations92
US5025024AJun 18, 1991
Therapeutically active fluoro-substituted compound
HAESSLE AB23 citations92
US5008278AApr 16, 1991
Therapeutically active compound and a process for its preparation
HAESSLE AB24 citations92
US4638047AJan 20, 1987
Enzyme inhibition
HAESSLE AB26 citations92
US5081154AJan 14, 1992
Metoprolol succinate
HAESSLE AB23 citations91
US5019584AMay 28, 1991
Therapeutically active chloro substituted benzimidazole
HAESSLE AB24 citations91
US4725691AFeb 16, 1988
2-[8-quinolinyl]-sulphinyl-1H-benzimidazole
HAESSLE AB40 citations91
US4544750AOct 1, 1985
Certain pyridyl-N-oxide intermediates for the preparation of omeprazole
HAESSLE AB37 citations91
US4045563AAug 30, 1977
Substituted 2-[pyridylalkylenesulfinyl]-benzimidazoles with gastric acid secretion inhibiting effects
HAESSLE AB152 citations91
US4045564AAug 30, 1977
Benzimidazole derivatives useful as gastric acid secretion inhibitors
HAESSLE AB75 citations91
US5075323ADec 24, 1991
Compounds including omeprazole in the treatment of glaucoma
HAESSLE AB57 citations90
US5039806AAug 13, 1991
Novel pharmacologically active compound pyridyl methylsulfinyl benzimidazole
HAESSLE AB72 citations90
US4803081AFeb 7, 1989
New pharmaceutical preparations with extended release
HAESSLE AB87 citations90
US5021433AJun 4, 1991
Novel pharmacological compounds
HAESSLE AB44 citations89
US4957745ASep 18, 1990
Pharmaceutical preparation
HAESSLE AB70 citations89
US4942040AJul 17, 1990
Pharmaceutical preparation and a process for its preparation
HAESSLE AB67 citations89
US4264611AApr 28, 1981
2,6-Dimethyl-4-2,3-disubstituted phenyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid-3,5-asymmetric diesters having hypotensive properties, as well as method for treating hypertensive conditions and pharmaceutical preparations containing same
HAESSLE AB70 citations88
US4695272ASep 22, 1987
Drug release device
HAESSLE AB45 citations87
US3998790ADec 21, 1976
Phenoxy-hydroxypropylamines, their preparation, and method and pharmaceutical preparations for treating cardiovascular diseases
HAESSLE AB34 citations87
US5215974AJun 1, 1993
Certain pyridyl[(methylthio- or methyl sulfinyl)-2 benzimidazol-2-yl]N-methyl phosphonates useful for treating gastric-acid secretion related diseases
HAESSLE AB26 citations86
US5106862AApr 21, 1992
Derivatives of benzimidazoles active as anti-ulcer agents
HAESSLE AB39 citations86
US4713445ADec 15, 1987
Renin inhibitors and treatments using them
HAESSLE AB21 citations81
US4650661AMar 17, 1987
Enzyme inhibitors
HAESSLE AB23 citations81
US4289795ASep 15, 1981
Method for preparing preparations having controlled release of an active component
HAESSLE AB23 citations81
US4261971AApr 14, 1981
Pharmaceutically preparation comprising a cardiac glycoside in combination with a polymer
HAESSLE AB19 citations81
US4772686ASep 20, 1988
Enzyme inhibition
HAESSLE AB8 citations74
US4609643ASep 2, 1986
Renin inhibitors, treatments and dipeptide synthesis
HAESSLE AB19 citations73
US5001161AMar 19, 1991
Pharmaceutical composition comprising metroprolol succinate
HAESSLE AB11 citations72
US5270056ADec 14, 1993
Particle having a dyed coke indicator and a pharmaceutical coating for parenteral administration of the pharmaceutical
HAESSLE AB7 citations71
US5149523ASep 22, 1992
Polystyrenesulfonate-drug complex and solid dosage forms thereof
HAESSLE AB19 citations70
US4336267AJun 22, 1982
Heart active compounds and methods of use
HAESSLE AB5 citations70
US4263325AApr 21, 1981
β-Receptor blocking compounds and treatment of cardiovascular disorders therewith
HAESSLE AB8 citations70
US4689331AAug 25, 1987
Substituted 2-pyridinyl benzimidazoles, and their use for inhibiting gastric acid secretion
HAESSLE AB12 citations68
US4562061ADec 31, 1985
Pharmaceutical preparation
HAESSLE AB10 citations68
US3996382ADec 7, 1976
Phenoxy-hydroxypropylamines, their preparation, and method and pharmaceutical preparations for treating cardiovascular diseases
HAESSLE AB11 citations68
US4165384AAug 21, 1979
Amide substituted phenoxy propanol amines
HAESSLE AB16 citations67
US4080471AMar 21, 1978
Use of substituted isopropylaminopropanols for inducing inotropic effects of the human heart
HAESSLE AB14 citations66
Showing the top 50 of 71 patents by PatentIndex Score.